Generic Baqsimi Availability

Last updated on Jun 11, 2025.

Baqsimi is a brand name of glucagon, approved by the FDA in the following formulation(s):

BAQSIMI (glucagon - powder;nasal)

• Manufacturer: AMPHASTAR PHARMS INC
  Approval date: July 24, 2019
  Strength(s): 3MG ^[RLD]

Is there a generic version of Baqsimi available?

No. There is currently no therapeutically equivalent version of Baqsimi available in the United States.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Baqsimi. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: Generic Drug FAQ.

Related patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• Nasal powder formulation for treatment of hypoglycemia
  Patent 10,213,487
  Issued: February 26, 2019
  Inventor(s): Mantripragada Sankaram & Piche Claude A. & Van Betsbrugge Jo Jan Filip
  Assignee(s): Eli Lilly and Company
  

  The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation.

  Patent expiration dates:

  • February 16, 2036
    
    ✓ 
    Patent use: TREATMENT OF SEVERE HYPOGLYCEMIA IN PATIENTS WITH DIABETES
    ✓ 
    Drug product
• Medication delivery systems and methods
  Patent 10,765,602
  Issued: September 8, 2020
  Inventor(s): Arnett Jaime Ray & Snow Andrew Thomas
  Assignee(s): Eli Lilly and Company
  

  The present disclosure relates to a medication delivery system including a medication administration device, a medication within the medication administration device, a container defining a cavity receiving the medication administration device, and a cap attached to the container and sealing the medication administration device within the cavity. The medication administration device includes an actuator extending from a body and operable to expel the medication by depressing the actuator into the body. The cap includes hold down members positioned to bear against the body of the medication administration device to prevent movement of the medication administration device toward the cap beyond a predetermined distance. The medication administration device is thereby prevented, inter alia, from prematurely discharging the medication during storage and transport.

  Patent expiration dates:

  • September 23, 2039
    
    ✓ 
    Drug product
• Device for dispensing a fluid product
  Patent 10,894,133
  Issued: January 19, 2021
  Inventor(s): Baillet Matthieu & Carballo Dolorès & Dulude Hélène & Poullain Franck
  Assignee(s): APTAR FRANCE SAS
  

  A dispenser device for dispensing a fluid or powder composition, the dispenser device comprising: a dispenser head () that is provided with a dispenser outlet () that is formed at the end of a hollow sleeve (); an air expeller () for generating a flow of air while the device is being actuated, said air expeller including a piston () that slides in an air chamber () between a rest position and a dispensing position, said air chamber () including a cylindrical body in which said piston () slides in airtight manner; and a reservoir () that contains a single dose of composition, said reservoir () including an air inlet () that is connected to said air expeller (), and a composition outlet () that is connected to said dispenser outlet (), said air inlet () including a composition retainer member () for retaining the composition in the reservoir () until the composition is dispensed, and said composition outlet () being closed by a closure element () that is force fitted in the composition outlet () of the reservoir (); said device further comprising a mechanical opening system () that co-operates with said closure element () so as to expel it mechanically from its closed position while the device is being actuated; said device further comprising an indicator () that, in the rest position before actuation, is in a first state, and that after actuation passes into a second state, the passage from the first to the second state informing the user that the device has been actuated, said first state being a visible state and said second state being a non-visible state, said device including a pusher element () that is secured to said piston (), and on which the user presses during actuation, said dispenser head () including a skirt () that is arranged around said air chamber (), said pusher element (), in its rest position before actuation, projecting axially out from said skirt (), and after actuation, being arranged inside said skirt (), said pusher element () including an indicator () that is visible before actuation and that is not visible after actuation.

  Patent expiration dates:

  • January 3, 2038
    
    ✓ 
    Drug product

Related/similar drugs

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer